But here’s the early and uncomfortable truth for enterprises: coding co-pilots rarely address the biggest bottlenecks and are not moving the needle on business outcomes as promised.

PARIS, FRANCE / ACCESS Newswire / October 16, 2025 / Owkin today announces the launch of K Pro, its co-pilot bringing advanced agentic AI to biomedical research and drug development. K Pro helps ...

Enterprise platform, queried through natural language, to help pharma, biotech, and investors make better decisions. High-quality biological patient data, enriched and integrated for use by AI agents.